`
James Vanden Bosch*
Clinical Orthobiological and Regenerative Medicine Specialist, USA
*Corresponding Author: James Vanden Bosch, Clinical Orthobiological and Regenerative Medicine Specialist, USA.
Received: November 06, 2025; Published: November 29, 2025
Fullerenes, a novel class of carbon nanostructures, are emerging as a promising therapeutic platform in regenerative medicine due to their potent antioxidant, cellular-modulating and redox-balancing properties. This white paper examines the integration of fullerene technology with stem cell and platelet-rich plasma (PRP) therapies, outlines a synergistic framework for improving regenerative outcomes, reviews the fundamental chemistry and mechanisms of fullerenes, and addresses translational challenges. These findings suggest fullerenes may serve as catalytic bioprotectants, forming a new foundation for next-generation regenerative therapies.
Keywords: Platelet-Rich Plasma (PRP); Fullerenes; Mesenchymal Stem Cells (MSCs.)
Citation: James Vanden Bosch. “Fullerenes in Regenerative Medicine: An Analysis of Therapeutic Potential with Stem Cells and Platelet-Rich Plasma".Acta Scientific Orthopaedics 8.12 (2025): 45-48.
Copyright: © 2025 James Vanden Bosch. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.